Mirvaso 3.3mg/g, Gel

7680651800025 CH-65180 Gel

Associated product:

MIRVASO gel 3.3 mg/g tb 30 g
Mirvaso 3.3mg/g, Gel
Mirvaso 3.3mg/g, Gel
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
30
Selling units
30
Measure
g
Galenic form
Gel
Galenic group
Salben

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
24/09/2025
Patient information leaflet
Français
24/09/2025
Patient information leaflet
Italien
24/09/2025
Summary of Product Characteristics
Allemand
24/09/2025
Summary of Product Characteristics
Français
24/09/2025
Summary of Product Characteristics
Italien
24/09/2025

Detailed composition

Substance Quantity Type Category
brimonidini tartras
5.0 MG Substance WIZUS
brimonidinum
3.3 MG Substance Wirkstoff (Principe actif)
carbomerum
- Substance HNIDK
E 218
1.0 MG Substance HBESI
phenoxyethanolum
- Substance Konservierungsstoff (Conservateur)
glycerolum
- Substance HNIDK
E 171
- Substance FNIDK
propylenglycolum
55.0 MG Substance HBESI
natrii hydroxidum
- Substance HNIDK
aqua purificata
- Substance HNIDK

Reimbursement information

Public price
CHF 57.15
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/05/2015

Authorization holder

Galderma SA

6300 Zug

Authorization information

Swissmedic authorization number
65180
Drug name
Mirvaso, Gel
Galenic form
GELK
ATC Code
D11AX21
Authorization status
Z
Dispensing category
B
First authorization
21/11/2014
Authorization expiration date
31/12/9999
IT Number
10.99.0.
Domain
Human medicine
Field of application
Symptomatische Behandlung des Gesichtserythems bei Rosazea

Package details

Description (FR)
MIRVASO gel 3.3 mg/g tb 30 g
Description (DE)
MIRVASO Gel 3.3 mg/g Tb 30 g
Market launch
21/11/2014
Narcotic (BTM)
No
Buy us a coffee Explore the data